Skip to main content

Why give Taxol (Paxel) before carboplatin?

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 2, 2024.

Official Answer by Drugs.com

Taxol (paclitaxel, Paxel) must be given before carboplatin because if carboplatin is given before Taxol, it stops Taxol from having an effect on cancer cells. This is called a scheduling interaction because when Taxol is given before carboplatin, there is little interaction and both agents work as intended.

The combination of carboplatin and paclitaxel is widely used to treat multiple solid tumors including ovarian, lung, and breast cancer. Research has shown that the pretreatment or simultaneous treatment with carboplatin inhibited Taxol-induced I-kappa, B-alpha degradation, and BCL-2 phosphorylation. Further analyses demonstrated that carboplatin could significantly interfere with the cytotoxic effects of Taxol on both mitotic arrest and apoptotic cell death unless Taxol was administered before carboplatin. These results indicate that the interaction between paclitaxel and carboplatin is highly schedule-dependent and the optimal schedule is Taxol (paclitaxel, Paxel) followed by carboplatin.

Why is Taxol and carboplatin used together?

A landmark study in 1996 showed that Taxol and carboplatin in combination was better for the treatment of advanced ovarian cancer because it was less toxic than the combination used at the time, Taxol and cisplatin. Carboplatin-Taxol in combination were also just as effective as cisplatin-Taxol. Carboplatin-Taxol have been a standard chemotherapy combination used for more than 25 years for the treatment of ovarian cancer. The combination is also used to treat many other solid tumors.

Related questions

How effective is Taxol and carboplatin?

The combination of carboplatin-Taxol is well tolerated and achieves a clinical response rate of 50% to 81% and an average progression free survival (PFS) of 13.6 to 19.3 months. Other findings include:

References
  • Taxol (paclitaxel) Updated 04/2021. E.R. Squibb & Sons, L.L.C. https://www.drugs.com/pro/taxol.html
  • Xiong X, Sui M, Fan W, Kraft AS. Cell cycle-dependent antagonistic interactions between paclitaxel and carboplatin in combination therapy. Cancer Biol Ther. 2007 Jul;6(7):1067-73. doi: 10.4161/cbt.6.7.4323. PMID: 17568189.

Read next

How do you manage neuropathy from chemo?

Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent and often distressing side effect of cancer treatment that affects the nerves. Common symptoms of CIPN are numbness, tingling, burning pain, and muscle weakness, which often occur in the hands and feet.

Continue reading

Will I lose my hair during chemotherapy treatment?

Chemotherapy-induced hair loss is common and usually temporary, caused by the drugs targeting rapidly dividing hair follicle cells. Hair loss typically starts a few weeks after treatment begins and regrows a few months after it ends.

Continue reading

What is chemo brain and how long does it last?

Chemo brain, also known as chemotherapy-induced cognitive impairment (CICI), chemo fog, or cancer-related cognitive impairment, refers to the cognitive difficulties experienced by many cancer patients during and after chemotherapy treatment. This condition is characterized by a noticeable decline in mental abilities, including memory, learning, attention, and executive functions such as planning and multitasking.

Continue reading

See also:

Related medical questions

Drug information

Related support groups